Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Nederlands Tijdschrift Voor Geneeskunde|June 23, 2022
[Medical tattooing, an unknown treatment option]Olivier J van Not, Rinus M J Souisa, Loes Souisa-Kooger, et al.
Dermatology (Basel, Switzerland)|July 13, 2023
Patient-Reported Outcomes of Medical Tattooing for Capillary MalformationsGinger Beau Langbroek, Julia Felsbourg, Albert Wolkerstorfer, et al.
JCO Precision Oncology|September 21, 2022
BRAF and NRAS Mutation Status and Response to Checkpoint Inhibition in Advanced MelanomaOlivier J van Not, Willeke A M Blokx, Alfons J M van den Eertwegh, et al.
European Journal of Cancer (Oxford, England : 1990)|February 6, 2025
Cost-effectiveness of treatment sequences for BRAF-mutant advanced melanoma in the Netherlands using a health economic modelHedwig M Blommestein, Saskia de Groot, Brenda Leeneman, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|February 22, 2025
Development of a Decision Model to Estimate the Outcomes of Treatment Sequences in Advanced MelanomaSaskia de Groot, Hedwig M Blommestein, Brenda Leeneman, et al.
Cancer|January 10, 2024
BRAF/MEK inhibitor rechallenge in advanced melanoma patientsOlivier J Van Not, Alfons J M van den Eertwegh, John B Haanen, et al.
International Journal of Cancer|February 27, 2023
Adjuvant treatment of in-transit melanoma: Narrowing the knowledge gap left by clinical trialsMelissa M de Meza, Willeke A M Blokx, Han J Bonenkamp, et al.
Cancers|January 21, 2023
Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma: A Propensity-Matched Outcome AnalysisMelissa M De Meza, Willeke A M Blokx, Johannes J Bonenkamp, et al.
JAMA Network Open|August 14, 2024
Long-Term Survival in Patients With Advanced MelanomaOlivier J van Not, Alfons J M van den Eertwegh, Hilde Jalving, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2023
Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignanciesOlivier J Van Not, Alfons J M van den Eertwegh, John B Haanen, et al.
Pageof 2